Family Medicine, Addiction Medicine · Wilkes Barre, PA
NPI
1124524350
Since 2018
Specialty
Family Medicine, Addiction Medicine
Code 207QA0401X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8 Church St
Wilkes Barre, PA, 18702
Phone (570) 808-3700
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
193 services
Medicare patients, 2024
29
Average age 56
Drug cost, 2024
$164K
322 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew J Kahari was code 99214 (office e&m - established), 79 times for 25 patients. In total Matthew J Kahari billed 193 services in 8 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 79 | 25 | $87.85 | $6,940 |
| 99484 Behavioral Health Services | Office | 48 | 21 | $38.10 | $1,829 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 47 | 17 | $11.69 | $550 |
By year: 2022 $5,831 for 73 services; 2023 $5,987 for 86 services; 2024 $11K for 193 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew J Kahari prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 205 prescriptions and refills. In total Matthew J Kahari wrote 322 Medicare prescriptions that cost $164K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 205 | 205 | 54 | $16K |
| Sublocade Buprenorphine | 38 | 38 | Under 11 | $75K |
| Brixadi Buprenorphine | 29 | 29 | Under 11 | $49K |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 19 | 19 | Under 11 | $4,930 |
| Vivitrol Naltrexone Microspheres | 12 | 12 | Under 11 | $18K |
Brand drugs: 98 claims; generic drugs: 224 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Matthew J Kahari were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.